Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alieysa Patel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Anaerobe|September 10, 2021
Non-steroidal anti-inflammatory drugs are not associated with increased risk of Clostridioides difficile infection: A propensity-score-matched case-control studyAdam M Ressler, Alieysa Patel, Krishna Rao
Msphere|June 23, 2021
Measurement of Klebsiella Intestinal Colonization Density To Assess Infection RiskYuang Sun, Alieysa Patel, John SantaLucia, et al.
Infection Control and Hospital Epidemiology|April 23, 2023
<i>Clostridioides difficile</i> infection surveillance in intensive care units and oncology wards using machine learningErkin Ötleş, Emily A Balczewski, Micah Keidan, et al.
Gut Pathogens|August 30, 2022
Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomesRachel Bernard, Muhammad B Hammami, Forest W Arnold, et al.
Msphere|June 23, 2021
Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting ColonizationKrishna Rao, Alieysa Patel, Yuang Sun, et al.
Nature Communications|August 1, 2022
Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infectionJay Vornhagen, Emily K Roberts, Lavinia Unverdorben, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Anaerobe|September 10, 2021
Non-steroidal anti-inflammatory drugs are not associated with increased risk of Clostridioides difficile infection: A propensity-score-matched case-control studyAdam M Ressler, Alieysa Patel, Krishna Rao
Msphere|June 23, 2021
Measurement of Klebsiella Intestinal Colonization Density To Assess Infection RiskYuang Sun, Alieysa Patel, John SantaLucia, et al.
Infection Control and Hospital Epidemiology|April 23, 2023
<i>Clostridioides difficile</i> infection surveillance in intensive care units and oncology wards using machine learningErkin Ötleş, Emily A Balczewski, Micah Keidan, et al.
Gut Pathogens|August 30, 2022
Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomesRachel Bernard, Muhammad B Hammami, Forest W Arnold, et al.
Msphere|June 23, 2021
Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting ColonizationKrishna Rao, Alieysa Patel, Yuang Sun, et al.
Nature Communications|August 1, 2022
Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infectionJay Vornhagen, Emily K Roberts, Lavinia Unverdorben, et al.
Pageof 1